Research. Education. Discovery.

World Hemophilia Day, an initiative of the World Federation of Hemophilia to raise awareness of hemophilia and other genetic bleeding disorders, is held annually on April 17. Hemophilia, an inherited blood disorder that affects mostly men, impairs the ability of a person’s blood to form clots. This blog highlights significant research into hemophilia that has received support from Canadian Blood Services.

In this blog, Dr. Brodie Nolan describes how Canadian Blood Services’ Blood Efficiency Accelerator Award Program (BEAP) is supporting the development of national best practices and a new registry for lifesaving transfusions that occur outside of hospitals.

Hematopoietic stem cell (HSC) transplantation therapy is used in the treatment of various blood disorders including leukemia, lymphoma, and sickle cell anemia. A recent review article published by Dr. Hari Maganti’s lab explores current advancements in pre-clinical research on the biology and mechanism of HSC homing and engraftment following transplantation.

The Specialization in Transfusion Science (STS) program is a new training program in development at the University of Alberta. Once launched, it will be the only program in Canada where medical laboratory technologists can develop advanced competencies in transfusion and earn credentials.

In this blog post, read about the 2023 Earl W. Davie Symposium held at the Centre for Blood Research (CBR) - a research event that brings together scientists, medical doctors, healthcare professionals, and trainees in the field of blood research and beyond.

Recipients of the Canadian Blood Services Lifetime Achievement Awards are individuals whose landmark contributions are recognized as both extraordinary and world class in the field of transfusion and transplantation medicine, stem cell or cord blood research in Canada and/or abroad.